Skip to main content

Luxshare Precision Posts 40.2% Revenue Growth In H1 2026

Image
Luxshare Precision Posts 40.2% Revenue Growth In H1 2026

SHERIDAN, WYOMING -- August 27, 2026 -- Luxshare Precision Industry Co., Ltd. (SZSE: 002475; HKEX: 02475) reported revenue of RMB 174.50 billion for the six months ended June 30, 2026, up 40.2% year over year. The Dongguan, China-based manufacturer posted net profit attributable to shareholders of RMB 7.84 billion, a rise of 18.0%. Gross margin expanded 17 basis points to 11.78%, driven by faster growth in higher-margin communications, data center and automotive electronics segments. The company disclosed the unaudited results on Aug. 28, 2026.

MWFN, Fiberpath, Hawkeye Ink Deal For 1,200-Mile Midwest Fiber Route

SHERIDAN, WYOMING -- August 27, 2026 -- Midwest Fiber Networks (MWFN) and Midwest Fiberpath, LLC, along with partner Hawkeye Land Co., announced an agreement on Aug. 27, 2026, to develop and commercialize approximately 1,200 miles of fiber corridors connecting Chicago, Omaha, Minneapolis and Kansas City. MWFN will serve as the key provider for connectivity services along Hawkeye's right-of-way corridor. Construction is scheduled to begin in Spring 2027, with engineering and materials procurement already underway and shipments due before the end of 2026.

AusperBio Closes $120M Series C For Hepatitis B ASO Therapy

Image
AusperBio Closes $120M Series C For Hepatitis B ASO Therapy

SHERIDAN, WYOMING -- August 27, 2026 -- AusperBio Therapeutics closed a $120 million Series C financing round on Aug. 27, 2026, bringing its total capital raised since 2024 to $360 million. The San Francisco-based biopharmaceutical company will direct proceeds toward Phase 3 registrational work and commercialization readiness for AHB-137, its lead antisense oligonucleotide therapy for chronic hepatitis B. RA Capital Management, L.P. joined the round as a new investor alongside an unnamed lead strategic investor.

Existing backers HanKang Capital, Sherpa Capital, InnoPinnacle Fund, Qiming Venture Partners, YuanBio Venture Capital and CDH Investments also participated. AusperBio described the round as reflecting sustained investor confidence in its oligonucleotide platforms.

Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

Image
Philips Wins FDA Clearance for Reusable SpO₂ Sensor Built to Hold Accuracy Across Skin Tones

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.

Philips Adds Alturion to Ultrasound Line, Targets High-Volume Clinical Workflows

Image
Philips Adds Alturion to Ultrasound Line, Targets High-Volume Clinical Workflows

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has launched Alturion, a new ultrasound system built for departments that run high patient volumes across varied exam types. The system pairs AI-powered workflow tools with imaging hardware designed to hold up across shift changes and multiple users. Alturion has received FDA 510(k) clearance and CE mark certification, making it available now in the U.S. and Europe. Philips positions the launch as an expansion of its ultrasound portfolio rather than a standalone product, built to share transducers and interface design with existing systems already in clinical use.

HD Advanced Technologies and PHENOGY Build Sodium-Ion Battery Manufacturing Base in Germany

Image
HD Advanced Technologies and PHENOGY Build Sodium-Ion Battery Manufacturing Base in Germany

SHERIDAN, WYOMING -- July 22, 2026 -- HD Advanced Technologies GmbH (HDAT), a wholly owned subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), has signed a two-part industrial partnership with Swiss battery developer PHENOGY AG. HDAT will take over contract manufacturing of PHENOGY's sodium-ion energy storage systems, covering everything from procurement to installation and maintenance. The two companies are also preparing a joint venture to develop and mass-produce sodium-ion battery cells, combining PHENOGY's cell chemistry with a HEIDELBERG printing process. The goal is a European-based supply chain for battery storage that does not depend on manufacturing capacity outside the region.

HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

Image
HEIDELBERG Adds ChromaStar Dispensing Line to Cut Spot Color Bottlenecks in Packaging Printing

SHERIDAN, WYOMING -- July 22, 2026 -- Heidelberger Druckmaschinen AG (HEIDELBERG) has introduced the ChromaStar series, a modular ink dispensing platform built to automate spot color production directly inside print shops. The system targets a persistent operational problem in packaging printing: manual, unstandardized spot color mixing that slows turnaround and ties up skilled staff. Four models — X, S, M, and P — scale from entry-level manual batch preparation to fully automated, high-volume industrial dispensing. HEIDELBERG frames the launch as an expansion of its Lifecycle consumables business and its role as a system integrator for packaging printers.

swissQprint America Opens Larger Illinois Headquarters and Closes Four Deals at Launch Event

Image
swissQprint America Opens Larger Illinois Headquarters and Closes Four Deals at Launch Event

SHERIDAN, WYOMING -- July 07, 2026 -- swissQprint America opened its new headquarters in West Dundee, Illinois, on June 24, marking both a physical expansion and the company's 10th anniversary serving the North American market. The Open House drew customers, partners and industry professionals to tour the newly completed building, which offers roughly 130% more space than the company's previous site. Four customers signed purchase contracts during the event itself, translating the celebration into immediate business. The larger facility is meant to expand customer support, technical service and training capacity across the United States and Canada.

Roche's Divarasib Beats Approved KRAS G12C Drugs in Head-to-Head Lung Cancer Trial

Image
Roche's Divarasib Beats Approved KRAS G12C Drugs in Head-to-Head Lung Cancer Trial

SHERIDAN, WYOMING -- July 07, 2026 -- Roche announced positive results from the phase III Krascendo 1 study, showing that its investigational KRAS G12C inhibitor divarasib outperformed the approved first-generation inhibitors sotorasib and adagrasib in patients with previously treated KRAS G12C non-small cell lung cancer. The study met both its primary and key secondary endpoints, with divarasib delivering statistically significant improvements in progression-free survival and overall survival. Roche plans to submit the data to health authorities and present full results at an upcoming medical meeting. The company positions the results as evidence that divarasib could become a new treatment standard for this genetically defined subgroup of lung cancer patients.

WINTIPAK Details Hong Kong Arbitration Award in Dispute With Greatview Holdings

Image
WINTIPAK Details Hong Kong Arbitration Award in Dispute With Greatview Holdings

SHERIDAN, WYOMING -- July 07, 2026 -- WINTIPAK AG has issued a public notice outlining the status of ongoing legal proceedings between itself and Greatview Holdings Ltd, a wholly owned subsidiary of Hong Kong-listed Greatview Aseptic Packaging Company Limited (GAPCL). The notice responds to a series of prior announcements from GAPCL and Shandong NewJF Technology Packaging Co., Ltd. describing court actions and arbitration filings against WINTIPAK and related parties. WINTIPAK's statement adds detail the company says was missing from those earlier disclosures, including an emergency arbitration award it obtained against Greatview Holdings before the other proceedings were filed. A Hong Kong High Court hearing on the matter is scheduled for May 19, 2026.